• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

CFO Malin Lundberg to leave Cell Impact

CIRegulatory press release02.07.2026, 10.00
Download the release

Malin Lundberg has decided to leave her position as CFO at Cell Impact and will remain with the company until 30 September 2026. Malin was appointed CFO in February 2024, having previously served as Business Controller since 2021.

"Malin has been a valued member of the management team and a steady hand during a challenging period for the company. I would like to thank her for her commitment and contribution and wish her every success in the future," says Daniel Vallin, CEO of Cell Impact.

Responsibility for the company's accounting and financial reporting activities will be assumed internally. The company does not intend to appoint a successor immediately and will revisit the recruitment process once anticipated key orders have been secured. This approach reflects the company's continued focus on cost discipline and operational efficiency.